Literature DB >> 6486781

Microbial models of mammalian metabolism: microbial reduction and oxidation of pentoxifylline.

P J Davis, S K Yang, R V Smith.   

Abstract

Fourteen microorganisms, including fungi, yeasts, and bacteria, were screened for their ability to metabolize the xanthine drug pentoxifylline. Thirteen cultures either reduced the drug to the alcohol metabolite or oxidatively cleaved the ketonic side chain to homologous carboxylic acid metabolites. The alcohol metabolite was the predominant or sole metabolite in all organisms, with conversions ranging from 6 to 91%. Preparative-scale production of the alcohol metabolite with Rhodotorula rubra (ATCC 20129) allowed for the isolation of this product with a 40% yield. Two organisms also produced the carboxylic acid metabolites at low levels (2 to 10%). The routes of metabolism in microbial cultures are the same as those reported in mammalian systems.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6486781      PMCID: PMC241512          DOI: 10.1128/aem.48.2.327-331.1984

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  12 in total

1.  Absorption, distribution, excretion, and metabolism of 1-(5-oxohexyl) theobromine (BL 191) in rats.

Authors:  K Fujimoto; S Yoshida; Y Moriyama; T Sakaguchi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1976-06       Impact factor: 1.645

Review 2.  Microbial models for drug metabolism.

Authors:  J P Rosazza; R V Smith
Journal:  Adv Appl Microbiol       Date:  1979       Impact factor: 5.086

3.  [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].

Authors:  H Denck
Journal:  Arzneimittelforschung       Date:  1973-04

4.  [Pharmacokinetic studies following oral administration of 3,7-dimethyl-1-(5-oxo-hexyl)xanthine- 14 C (BL 191- 14 C) in rats, dogs and man].

Authors:  O Christ; K Gleixner; H M Kellner; R Müller; W Rupp
Journal:  Arzneimittelforschung       Date:  1972-11

5.  [Structure of excretion products of 3,7-dimethyl-1-(5-oxo-hemyl)-xanthine (BL 191) in man].

Authors:  H J Hinze; G Bedessem; A Söder
Journal:  Arzneimittelforschung       Date:  1972-07

6.  [Analysis of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthin (BL 191). 2. Chromatography and quantitative determination of BL 191].

Authors:  H J Hinze
Journal:  Arzneimittelforschung       Date:  1971-12

7.  Source of oxygen in the conversion of 2-tridecanone to undecyl acetate by Pseudomonas cepacia and Nocardia sp.

Authors:  L N Britton; J M Brand; A J Markovetz
Journal:  Biochim Biophys Acta       Date:  1974-10-16

8.  Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.

Authors:  J M Porter; B S Cutler; B Y Lee; T Reich; F A Reichle; J T Scogin; D E Strandness
Journal:  Am Heart J       Date:  1982-07       Impact factor: 4.749

9.  Microbial transformations of warfarin: stereoselective reduction by Nocardia corallina and Arthrobacter species.

Authors:  P J Davis; J D Rizzo
Journal:  Appl Environ Microbiol       Date:  1982-04       Impact factor: 4.792

10.  Microbial models of mammalian metabolism: O-dealkylation of para-alkoxybiphenyls.

Authors:  R V Smith; S A Milton; P J Davis
Journal:  Appl Environ Microbiol       Date:  1982-07       Impact factor: 4.792

View more
  1 in total

1.  Microbial transformations and bioconversions. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-12       Impact factor: 2.926

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.